No Data
No Data
Rohto Pharmaceutical's Profit Down Nearly 7% in Fiscal Q1
Honda's operating profit in Q1 increased by 22.9%, reaching 484.7 billion yen.
Honda (7267) announced its first quarter results for the fiscal year ending in March 2025, with sales revenue of 5 trillion 404.858 billion yen, a year-on-year increase of 16.9%, and operating profit of 484.705 billion yen, a year-on-year increase of 22.9%. This exceeded the consensus (around 473 billion yen). The global number of passenger carried increased mainly in India and Brazil in the motorcycle business. The strong sales of hybrid models also continued in the four-wheel business. [Positive evaluation] 5858 STG, 79.
Rohto Pharmaceutical Sees Growth and Dividend Revision
Rohto Pharmaceutical Sees Robust Q1 Growth, Ups Dividend
Rohto Pharmaceutical: Overview of consolidated financial statements for the first quarter (April 1 to June 30) of the fiscal year ending March 2025.
Rohto Pharmaceutical: Announcements of individual stocks regarding revisions in financial estimates and dividend forecasts (increase in dividends).